Literature DB >> 30890428

Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesis.

Lixian Chen1, Tianhao Zhou2, Nan Wu2, April O'Brien2, Julie Venter2, Ludovica Ceci2, Konstantina Kyritsi2, Paolo Onori3, Eugenio Gaudio3, Amelia Sybenga4, Linglin Xie5, Chaodong Wu5, Luca Fabris6, Pietro Invernizzi7, David Zawieja2, Suthat Liangpunsakul8, Fanyin Meng9, Heather Francis9, Gianfranco Alpini9, Qiaobing Huang10, Shannon Glaser11.   

Abstract

Melatonin, a neuroendocrine hormone synthesized by the pineal gland and cholangiocytes, decreases biliary hyperplasia and liver fibrosis during cholestasis-induced biliary injury via melatonin-dependent autocrine signaling through increased biliary arylalkylamine N-acetyltransferase (AANAT) expression and melatonin secretion, downregulation of miR-200b and specific circadian clock genes. Melatonin synthesis is decreased by pinealectomy (PINX) or chronic exposure to light. We evaluated the effect of PINX or prolonged light exposure on melatonin-dependent modulation of biliary damage/ductular reaction/liver fibrosis. Studies were performed in male rats with/without BDL for 1 week with 12:12 h dark/light cycles, continuous light or after 1 week of PINX. The expression of AANAT and melatonin levels in serum and cholangiocyte supernatant were increased in BDL rats, while decreased in BDL rats following PINX or continuous light exposure. BDL-induced increase in serum chemistry, ductular reaction, liver fibrosis, inflammation, angiogenesis and ROS generation were significantly enhanced by PINX or light exposure. Concomitant with enhanced liver fibrosis, we observed increased biliary senescence and enhanced clock genes and miR-200b expression in total liver and cholangiocytes. In vitro, the expression of AANAT, clock genes and miR-200b was increased in PSC human cholangiocyte cell lines (hPSCL). The proliferation and activation of HHStecs (human hepatic stellate cell lines) were increased after stimulating with BDL cholangiocyte supernatant and further enhanced when stimulated with BDL rats following PINX or continuous light exposure cholangiocyte supernatant via intracellular ROS generation.
Conclusion: Melatonin plays an important role in the protection of liver against cholestasis-induced damage and ductular reaction.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arylalkylamine N-acetyltransferase; Clock genes; Melatonin receptors; Reactive oxygen species; Senescence

Mesh:

Substances:

Year:  2019        PMID: 30890428      PMCID: PMC6993622          DOI: 10.1016/j.bbadis.2019.03.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  44 in total

Review 1.  Functional role of cellular senescence in biliary injury.

Authors:  Luke Meng; Morgan Quezada; Phillip Levine; Yuyan Han; Kelly McDaniel; Tianhao Zhou; Emily Lin; Shannon Glaser; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2015-01-22       Impact factor: 4.307

2.  Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection.

Authors:  P H McGuinness; D Painter; S Davies; G W McCaughan
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

Review 3.  Melatonin and the theories of aging: a critical appraisal of melatonin's role in antiaging mechanisms.

Authors:  Rüdiger Hardeland
Journal:  J Pineal Res       Date:  2013-09-23       Impact factor: 13.007

4.  Melatonin protects against lipid-induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice.

Authors:  Nabanita Das; Ashok Mandala; Shamreen Naaz; Suresh Giri; Mukul Jain; Debasish Bandyopadhyay; Russel J Reiter; Sib Sankar Roy
Journal:  J Pineal Res       Date:  2017-03-27       Impact factor: 13.007

5.  Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis.

Authors:  James H Tabibian; Steven P O'Hara; Patrick L Splinter; Christy E Trussoni; Nicholas F LaRusso
Journal:  Hepatology       Date:  2014-04-25       Impact factor: 17.425

6.  Anti-angiogenic activity of melatonin in advanced cancer patients.

Authors:  P Lissoni; F Rovelli; F Malugani; R Bucovec; A Conti; G J Maestroni
Journal:  Neuro Endocrinol Lett       Date:  2001       Impact factor: 0.765

7.  The pineal and regulation of fibrosis: pinealectomy as a model of primary biliary cirrhosis: roles of melatonin and prostaglandins in fibrosis and regulation of T lymphocytes.

Authors:  S C Cunnane; M S Manku; D F Horrobin
Journal:  Med Hypotheses       Date:  1979-04       Impact factor: 1.538

8.  Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis.

Authors:  Shilian Hu; Shi Yin; Xiaodong Jiang; Dabing Huang; Gan Shen
Journal:  Eur J Pharmacol       Date:  2009-07-02       Impact factor: 4.432

9.  Melatonin suppresses activation of hepatic stellate cells through RORα-mediated inhibition of 5-lipoxygenase.

Authors:  Shiva Shajari; Almudena Laliena; Janette Heegsma; María Jesús Tuñón; Han Moshage; Klaas Nico Faber
Journal:  J Pineal Res       Date:  2015-09-15       Impact factor: 13.007

10.  Decreased MT1 and MT2 melatonin receptor expression in extrapineal tissues of the rat during physiological aging.

Authors:  Marina Sánchez-Hidalgo; Juan Miguel Guerrero Montávez; María Del Pilar Carrascosa-Salmoral; María Del Carmen Naranjo Gutierrez; Patricia Judith Lardone; Catalina Alarcón de la Lastra Romero
Journal:  J Pineal Res       Date:  2008-05-28       Impact factor: 13.007

View more
  6 in total

1.  Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury.

Authors:  Nan Wu; Guido Carpino; Ludovica Ceci; Leonardo Baiocchi; Heather Francis; Lindsey Kennedy; Tianhao Zhou; Lixian Chen; Keisaku Sato; Konstantina Kyritsi; Vik Meadows; Burcin Ekser; Antonio Franchitto; Romina Mancinelli; Paolo Onori; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  Hepatology       Date:  2021-11-24       Impact factor: 17.425

Review 2.  Possible application of melatonin treatment in human diseases of the biliary tract.

Authors:  Leonardo Baiocchi; Tianhao Zhou; Suthat Liangpunsakul; Lenci Ilaria; Martina Milana; Fanyin Meng; Lindsey Kennedy; Praveen Kusumanchi; Zhihong Yang; Ludovica Ceci; Shannon Glaser; Heather Francis; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-11       Impact factor: 4.052

3.  Beneficial effects of melatonin on liver fibrosis: A systematic review of current biological evidence.

Authors:  Beatriz San-Miguel; Paula Fernández-Palanca; José L Mauriz; María J Tuñón; Javier González-Gallego
Journal:  J Cell Physiol       Date:  2022-04-11       Impact factor: 6.513

Review 4.  Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies.

Authors:  Keisaku Sato; Fanyin Meng; Heather Francis; Nan Wu; Lixian Chen; Lindsey Kennedy; Tianhao Zhou; Antonio Franchitto; Paolo Onori; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  J Pineal Res       Date:  2020-03-04       Impact factor: 13.007

5.  The Apelin-Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis.

Authors:  Lixian Chen; Tianhao Zhou; Tori White; April O'Brien; Sanjukta Chakraborty; Suthat Liangpunsakul; Zhihong Yang; Lindsey Kennedy; Romil Saxena; Chaodong Wu; Fanyin Meng; Qiaobing Huang; Heather Francis; Gianfranco Alpini; Shannon Glaser
Journal:  Hepatology       Date:  2021-05-22       Impact factor: 17.298

6.  Melatonin prevents oxidative stress, inflammatory activity, and DNA damage in cirrhotic rats.

Authors:  Josieli R Colares; Renata M Hartmann; Elizângela G Schemitt; Sandielly R B Fonseca; Marilda S Brasil; Jaqueline N Picada; Alexandre S Dias; Aline F Bueno; Cláudio A Marroni; Norma P Marroni
Journal:  World J Gastroenterol       Date:  2022-01-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.